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Abstract. This study was performed on patients (n = 
18) suffering from strictly defined hyperdynamic 
septic shock. Plasma faclors (C-reactive protein, acid 
al-glycoprotein, fibri nogen, fibrinopeptide A, fi-
brinogen-fibrin split products, factor XIII, anti-
thrombin III, complement factors C3 and C4, inter-
et-trypsin-inhibitor and CtrmacrogJobulin) measured 
during hyperdynamic septic shock were highly ab-
normal. The actjvat ion and consumption of dotting, 
fibrinolytic and complement factors due to system-
speeific proteinases (such as thrombokinase or plas-
minogen aetivators) seemed to be intensified by the 
nonspecific proteolytic activity of granuloeytic pro-
teinases probably released by the action of endo-
toxins. Possible therapeutie measures {o maintain the 
endogeneous defenee meehanism against enhaneed 
proteolysis during septic shoek are diseussed. 
Key words: Septic shoek - Coagulation - Fibrinoly-
tie and eomplemem systems - Granulocytie pro-
teinases - Nonspecifie proteolysis - Proteinase 
inhibitors 
Introduction 
Bacterial sepsis and its most serious eomplication, 
septic shock play an essential role in the pathogenesis 
of acquired coagu!ation disorders which may lead to 
disseminated intravaseular coagulation (10, 11 , 13, 
18a, 20]. Tbe endotoxins (phospholipid-polysae-
charide-peptite eomplexes) released from the cellular 
walls of gram negative baeteria primarily cause enda-
thelial lesions [8]. which secondarily aetivate the dot-
ting, fibrinolytic and complement systems. 
It is also known from a number of studies that in 
the course of serious inllammatory processes, a 
massive degranulation of leukocytes occurs caused 
djrectly by endotoxin and inllammalOry media tors 
released from other ceIls. Consequently, lysosomal 
enzymes are liberated which normally degrade phago-
cytozed material within the cells. By their release from 
the cells, however, (hey intensify the inflammatory 
process in at least two di ffe rent ways. Proteinases 
such as thrombokinase and plasminogen activators 
activate the clotting, fibrinolytic and eomplemem 
systems by inducing proenzyme-enzyme eonversion 
due to specific proteolytic cleavages. These reactions 
are responsible for the well-known specific consump-
tion of the blood proteins leading to disseminated in-
travascular coagulation (DIC). The severe consump-
tion of plasma proteins also seems to be caused, to a 
large degree, by non-specific degradation by leukocy-
tic proteinases such as elastase and cathepsin G 
Iiberated by endotoxin (14 , 23J; acme leukemia and 
the Gram-negative sepsis are clinically relevant 
examples {14J. The possibly Iife-threatening eoagula-
lion disturbances observed during these disorders are 
caused mainly by released granuloeytic enzymes. 
To obtain further information about the degree of 
involvement of specific activation or nonspecific prO-
teolytic degradation in the consumption of plasma 
factors during septic shock, we followed the plasma 
levels of selected factors. A dinical [rial was carried 
out in patients suffering from clearly defined hyper-
dynamic septic shock . 
Materials and Methods 
Palients 
Eighteen patients (13 males. 5 females) with septic 
shock were examined. In 13 patiems, the septic foei 
were localiud in the abdomen, two patiems had ab-
seesses in the urogenital region. Isolated pneumonia 
was responsible for the sepsis in two other patients. In 
one case (patient 14) extra-abdominal primary disease 
was found (Table I). Since very d ifferent clinieal 
courses are described as hyperdynamie septic shock 
{4, 101, the patients in this study had to show the fol-
lowing: 
I. Sepric CriJerio 
raised temperatures with a minimum of at least 
38.5 °C 
two positive blood eultures and/or positive cul-
tures in other related sampies 
leukoeytosis wirh more than 15000 cells/ mm3 or 
leukopenia with less than 5000 cells/mm3 
thromboeytopenia with less than 130000 eellsl 
mm' 
- all the d inieal signs of septie shoek. 
2. Hemodynamic Criteria 
eardiae index above 6 (I x min -I X m -2 body 
surfaee) 
total peripheral vascular resistanee (TPR) below 
600 dyn x s x cm-s 
- mean arterial blood pressu re within the normal 
range (mmHg). 
Patients satisfying all these condilions were 
observed for 4 days. All hemodynamic and b io-
chemical parameters were noted after 6, 12, 18,24, 
36, 48, 72 and 96 h (x, - x\I6) after taking the init ial 
values (io). 
Therapy 
The following mcasures were performed: Surgical in-
tervention for the septic focus, volume substitution 
with human albumin regulated aceording to the pul-
monary capillary wedge pressure, continuous low 
dose heparin therapy (200-400 U/h), infusion of 
100 - 400 J,tg/min dopamine (to maintain urine output 
of at least 80-100 mllh), administration of 30 mg/kg 
body weight of methylprednisolone every 6 h up to 48 
h, medication with antibiotics aceording to the 
sensitivity patlerns of lhe microorganisms, and paren-
teral nutrition as weil as mechanicaJ ventilatory assist-
anee. 
BOCleriologicol Exominotions 
Baeteria were detccted in blood cultures, tracheal 
secretions. drainages and microscopie preparations of 
wounds. All results were eonfirmed by at least one 
finding identical to the original. Blood cultures 
(aerobic and anaerobic) were taken at the beginning 
of the episode of feve r or during tigors and were in-
cubated immediately. 
Hemodynamic Parometers 
The catheters (CYP, Part) were inserted under aseptie 
conditions and were lefl in for the period of 
treatment. A 3·lumen thermistor-balloon-catheter (7-
F-Swan-Oanz-Thermodilution eatheter), placed in the 
pulmonary anery from the subclavian vein, was used 
to measure cardiae output with a cardiac output com-
puter (no. 9510, Edward's Laboratories). lnjections 
of 10 mt 0.9% NaCI (0° - 5 oe) were made at the same 
phase of the respiratory eyele. The results of the 
cardiae output are the average values of three 
measurements eaeh done immediately one after the 
Ol her (range 5% -10'70). The cireulatory variables 
calculated from these data (eardiae index, TPR) were 
ascertained using standard formulae. 
Hemolologicol Measuremenls 
Leukocytcs were eounted using a Coulter-Counter-
Model B. Thromhocyte counts were performed using 
the Neubauer's eounting chamber. 
The mean values of lactate in blood were increased 
(3.4 ± 0.5 mrnol/ l, p :S 0.005) at the beginning of the 
observation period. TIle values for patients who died 
during the shock phase increased after 96 h up to 12.8 
± 3.3 mmolll. On the other hand, lhe levels oflactate 
decreased (2.4 ± 0.3 mm/ l) after 96 h in palients who 
survived the shock phase. 
Estimalion 01 Plasma Factors 
Plasma sampies were prepared frorn specimens of 
citrated blood. If the sam pies were not anaJyzed im-
mediately they were stored ar - 30°C. 
Plasma concentrations of acid Ctl·glyeoprotein, C-
reactive protein, eomplement faetors C3, C4 and 02-
macroglobulin (a2M) were determined by immunodif-
fusion with standardized immunodiffusion plates 
(partigen plates from Behri ngwerke AG, Marburg). 
Estimation of antithrombin IU concentration in 
plasma was carried out by electro~immunodi ffusion 
aceording to Laurell [21) . The functional activity of 
fib rin-stabilizing fae tor XIII was ehecked by the 
"Gerinnungsfaktor XIII- Schnellreagenz" (Behring-
werke AG, Marburg No. 0TXS 10). Fibrinogen was 
determined aceording to Hafter and Graeff [12J. 
Estimation of fibrinopept ide A was performed by 
radioimmunoassay (32). The fibrinogen-fibrin split 
products were semiquamitatively deterrnined with the 
staphyloeoccus dumpi ng test (No. 0FKW 10 Beh-
ringwerke AG, Marburg). 
Native inter·alpha-trypsin·inhibitor (IT 160000) 
and its acid stable degradation produet (IT 30000) 
were detected as deseribed recently [17}. 
Statistics 
UnJess otherwise indicated, results obtained from the 
blood specimens of our patients were compared with 
nonnal values (xn) stated in the li terature. 
Statistical evaluation was performed by the 
Studem~T·Test. p values :s 0.05 were considered to 
be significam. 
Results 
The present examinations were carried out in a pro· 
sptttive manner with 18 patiems satisfying all the 
criteria of hyperdynamic septie shock. Within the ob~ 
servation period of 96 h, four patients died and the 
remainder survived the shock event. However, all 
T.ble 1. Bacteriological re$ulu in hyperdynamic septic shock (n _ 
Patienu Blood culture Trachea 
1 Klebsiella, StreptOCOCCU5 Klebsiella 
2 Pyoceaneus, E. coli E. coli 
, Pyoceaneus Klebsiella, 
Enterobacter Pyoceaneus 
4 Klebsiella Klebsiella 
, Klebsiella negative 
• negative E. coli Staphylococcu$ 
7 Enlerococcus, Str~to- Streptococcus, 
coccus, E. coli E.ooli 
8 Serratia, Klebsiella Serratia, 
Klebsiella 
, Streptococcus Str~tOCOCCU$, 
KlebsieUa 
10 E. coli negative 
11 negative Klebsiella 
12 negative negative 
13 PyoceaneUl, Candida a1b. Candida alb. 
Streptococcus 
14 Oostridium, negative 
Pyoceaneus 
I' negative Klebsiella, 
18) 
these patients except one succumbed within 6 and 84 
days after the end of the observation period either due 
10 the direct sequelae of shock (respiratory insuf~ 
ficiency, oüguria or anuria) or to toxie heart failure 
and underlying maJignanl disease. 
Bac/eriology 
The bacteriological resullS of blood and other cul(ures 
afe shown in table 1. Gram~negative bacteria pfe~ 
dominate. Despite performing daily blood cultures, 
no organisms were detected in the blood specimens of 
six patients, probably because of prior treatment with 
antibiotics. These six subjccts, however, contained 
organisms in the other sam pies examined. 
Drainage Wound $pecimtn Urin 
negative negative 
negative Staphylococcus 
E. coli, Py~aneus E. coH 
Pyoceaneus negative negative 
Klebsiella negative negative 
E. coli Enterococcus E. coli 
E.OOü negative Klebsiella 
negative negative negati~ 
Klebsiella E. coli, Suepto- E. coli (~) 
coccus. Klebsiella 
negative Staphylococcus negative 
E.ooli negative negative 
Klcbsie!1a, negative negative 
E. coli 
negative negative KlebsielJa 
Pyoceaneus Klebsiella Candida alb. 
Pyoceaneus 
Oostridium. Clostridium, negative 
Pyoceaneus Py~aneU! 
Klebsiella, Klebs.iella, E.ooli 
E. coli, PyoceaneU$ E. coli, E. coU Klebsiella 
Pyoceaneus 
I' E. ooli, Enterococcus E. coU E. col; negative negative 
17 negative E. coli E. coli E. coli E. coli 
I' negative E. coli E. coli EntcrQCOCCus, negative E.ooli 
Bacteria were detected in blood cultufe$, tracheal sccretions, drainilje$ and wound specimens. All roult! were oonti rmed by !wo identical 
tindings 
Table 2. Course of temperature, hemodynamic (cardiae index, total periphcral vaSCllla r resistane~) and hematological (leukocytes, throm· 
bocytes) variables in patients (11 '" 18) sllfferiog from hyperdynamic septic shoci:: 
HOllrs 
Variable 0 6 12 18 24 J6 48 n 96 
T~mpera[ure (oq 38.8 38.3 37 .7 37.3 37.5 37,4 37.7 37.5 38.3 
± 0.3 ± 0.2 ± 0.2 ± 0.1 ± 0.2 .:t 0.2 .:t 0.2 ± 0.1 ± 0.2 
Cardiae index 6.' 6.3 ,., ,., ,., '.1 '.0 4.8 4.3 
(I x min - t x m- z) ± 0.3 ± 0.3 ± 0.2 ± 0.3 ± 0.2 .:t 0.3 ± 0.3 ± 0,4 ± 0.6 
TPR 545.8 476.8 568.7 703 .5 682.0 715,4 720.0 812.2 868.5 
(dyn x 5 x ern - I) ± 4\.4 ± 33.3 ± 43.9 ± 56.8 ± 73 .7 ± 71.1 ± 40.0 ± 62.3 ± 78,4 
part (mmHg) 81.3 77.3 88. 1 94.3 89.5 89,4 94.0 99.6 93.9 
± 5.7 ± 3.5 ± 3.6 ± 4.1 ± 3.9 ± 5.3 ± 3.6 ± 4.7 ± 5.8 
L~ukocyet~s 18578 17089 18078 18381 15506 16286 
(mm - l ) ± 2586 >2344 ± 1842 ± 2765 ± 2044 ± 1870 
Thrornbocytes 129139 99212 80775 97215 95806 80992 
(mrn - 1) ± 17741 ± 15261 ± 13398 .:t 15888 ± 15125 ± 21737 
Mcan valucs x ( ± SEM) ar~ indicatcd at ~aeh lest during the whole observation pcriod (96 h) 
Hemodynamic Data 
The cardiac index of all palienls showed mean values 
of 6.5 ± 0.3 I X min - ] X m _2 at the beginning and 
4.3 ± 0.61 X min - t X m - 2four days later(Table2). 
The initial value was twice as high as the standard 
range (2.5-3 .51 x min - t x m - 2). The cardiac index 
of the patients who died during the investigation 
phase decreased to weil below the normal value. 
The total peripheral vascular resistance (TPR) 
(545 .8 ± 41.4 dyn x s x cm - 5) was significantly 
below the normal range (900 - 1200 dyn x s x cm - s) 
in the whole group (Tablc 2), characteristic of hyper-
dynamic shock. With therapy, especially volume 
replacement , TPR tended towards normal values of 
868.5 ± 78.4 dyn x s x cm - 5 after 96 h. The four 
patients who died during the observation period 
showed a more rapid approach of TPR to standard 
values. This was, however, rclated to a falling cardiac 
index. 
Hematological Dara 
Fifteen of the 18 patients (Table 2) had a marked leu-
kocytosis with an average of 21366 ± 2526 cells/mm3 
at the beginning of the observation period . This vaJue 
decreased slightly until the 96th h (17254 ± 1728 
cells/mm3). 
Three of the 18 patients (10, 11, and 15) had a con-
stant leukopenia with 4633 ± 1073 ceIls/mm3 at the 
beginning and 3633 ± 555 cells/mm3 after 96 h. 
The numbers of thrombocytes were low, with an 
average of 129139 ± 17 441 cells/mm3 (xn: 200000 to 
350000 cells/mm3). The values decreased unti l the 
24th h to 80757 ± 13 396 cells/mm3 and remained 
at [hat level to the end of the observation period 
(fable 2). 
Acule-Phase Proteins 
The so-called acute·phase proteins are synthesized in 
the liver at higher rates during severe inflammatory 
processes . As the shock evcnt may significantly 
impair liver funclion [22, 29]. a reduclion o r rhe ef-
ficiency of protein synthesis by the liver had to be ex-
c1uded. This was achieved by measuring the plasma 
levels of the acute-phase proteins fibrinogen, C-reac-
live protein, and acid al-glycoprotein. The levels of 
these three were significantly increased during the ob-
servation period. 
Fibrinogen: AI the beginning of the trial, the average 
fibrinogen level reached the upper limit of the normal 
range (Xo = 359.7 ± 23.4 mgOJo; xn = 180 - 380 
mgOJo). During the observation period, the values 
decreased to x96 = 293.5 ± 17.4 mgOJo, but this dif-
ference was not significant (p > 0.05) . As fibrinogen 
is probably consumed due [0 the activation of the 
dorting cascade, the true plasma levels might be 
c1carly higher than the given values. 
Creaclive protein [28] is cOßsidered to be an noo-
specific protein accompanying primary and secondary 
inflammatory processes. lts plasma level increases 
prior tO lhose of other acute-phase proteins. There-
fore, detcrmination of C-reaclive protein is of special 
interest in achieving an early diagnosis. The plasma 
levels of C-reactive protein were significantly increas-
ed due to the massive inflammatory process during 
the observation period (xo = 13.5 ± 1.3 mg/dl;)(96 = 
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Fig. 1. Plasma concentrations of fibrinopeplide A (FPA) and 
fibrinogen-fibrin splil producls (FSP) during 96 h of hyperdynamic 
septic shock. Thc: wrvcs fcpresent mean values x of n : 18 pa-
ticms; standard deviations (± SEM) of x are indiC3ted for each test 
poin!. (Normal; FPA < J ng/ ml; FSP < iO ~g/ml) 
(FPA ,FSP --- -) 
Acid a[-glycoprorein, anolher protein accompanying 
inflammatory reactions. serves mainly for thc diag-
nosis of liver discases. Thc meaning of its increase, 
however. is not yet elear [28]. In (his study, the 
plasma levels of the acid u[-glycoprotcin were signif-
icantly above the normal range of the observation 
period (xn: 9Omg/dl ~ lOOOJo;Xo = 139.3 ± 7.90/0 or 
)(96 = 123.9 ± 15.20/0). 
Faclors 01 the Clotling and Fibrinolytic Systems 
Even at the beginning of the observation period the 
values of jibrinopeptide A (Fig. 1) wcre four times 
higher than the standard values (xo "" 13. 1 ± 2.7 
ng/ml; xn = <3.0 nglml). They remained at that 
level during the 4-day investigation phase (x96 = 18.1 
± 4.5 nglml). 
The plasma levels of the fibrinogen-fibrin split 
products (Fig. 1) just increased abovc the standard 
range (xo = 21.4 ± 4.1 Ilglml; xn = 5 - 10 Ilglml) 
and returned to normal in the course of 96 h (X<}6 = 
10.7 ± 1.7Ilglml). 
Factor XIII (Fig. 2) was significantly reduced 
from the onset (xo = 46.1 ± 4.90/0 of the standard 
value). It increascd only slightly during the observa-
tion period (x96 = 52.9 ± 4.80/0 of the standard 
value) . 
The plasma concentration of antithrombin ll] 
(Fig. 2) showed a highly significant reduction at the 
beginning of the observation period (Xo = 47.4 ± 
2.80/0 of the standard value) . The antithrombin JlI 
level of the surviving patients increascd slowly over 
Fig. z. Plasma concentrations of amithrombin 111 and factor XIII 
during 96 h of hyperdynamic septic shock. Standard dr:viation~ ( ± 
SEM) of the rnean values x (n '" 18 patiems) a re indicated for each 
test point. Ordinate: percentage or thr: proteins related to standard 
values. Abscissa: observation !)eriod. (Normal: AT 111: 
75~0 - 1000/0; F XIII: 80% - 120%) 
(AT 111 , FXlII ----) 
thc course of 96 h (x+ = 58.9 ± 5.60/0 of the 
standard value). The value of the four patients who 
dicd during the septic shock phase, however, decreas-
ed terminally beJow the starting values (X96 = 32.0 ± 
4.0070 of the standard value). 
Complemenl Faclors 
A significantly low plasma concenrralion of C3 (xo = 
70.1 ± 4.30/0 of the normal value) was found at the 
start of the septic shock phase (Fig. 3) and showed no 
tendency to return to normal during the following 4 
days (x96 = 65.3 ± 6.7% of the normal value). In 
contrast, the plasma level 01 C4 was not significantly 
reduced during the whole observation period. Values 
of Xo = 82.2 ± 11.2% and x\l6 = 74.5 ± 11.2% of the 
normal values are still within the normal range of this 
factor (Fig. 3). 
lnter-a-Trypsin-Inhibitor (ITI) and arMacrogfobulin 
(a2 M ) 
As a screeing investigation, !TI was examined in the 
blood sam pies of only ten patients (1 -10). A con-
stant significant reduction (p .:S: 0.001) of native, acid-
labile ITIwas observed (Xo = 42.7 ± 3.6 mIU/ml; X96 
= 46.4 ± 3.4 mIU/ml; xn = 50-80 roIU/ml) dudng 
the whole observation period (Fig. 4). In contrast, the 
concentration of the acid~stable ITI-derived inhibitor 
was constantly and significantly (p ::s; 0.01) increased 
(xo = 15.7 ± 1.7 mIU/ml; x% "" 21.7 ± 2.5mIU/ml; 
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Fig. 3. Pillsma levels cf complcmem factors C3 (upper curve) and 
C4 lIower curve) during 96 h of hyperdynamic septic shock. Thc 
prolein amounts 3fe indicilled as thc percentage relatcd 10 standard 
values. Standard deviations (± SEM) of i (n '" 18 patients) are rc-
presented for cach test point [Normal; C3: 55 -120 mg/d] 
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Hg. 4. €13.S1J13 levels of native imtt-a-I rypsin-inhibitor (ITI](,OlX!O. 
upper curvc), thc acid-stabile derivative (lTl30000• middlc cu rve, 
colte<! line) and Ct2-macroglobulin (Iower curve) during 96 h of hy-
perdynamic septic shock. Thc curves repn:sent mean values (ii) cf I! 
.. 10 (ITI) or n .. 18 (a2M) patients; slandard devialions (± SEM) 
of x are indicaled for each test point. ITI amounts are represenled 
as milli·inhibi to r units (mIU) per ml test plasma; (l1M·concentra· 
tion is indicated as the percentage related 10 standard values. 
(Normal: ITI I60000: 50 - 80 m IU/ml; ITTloooo: 6 - 9 m IU/ml; (12M: 
70 - 130OJo) 
The average plasma level of armacroglobulin 
(a2M) was significantly (p :s 0.005) diminished in all 
pati'ents at the beginning of the trial (xo = 48.8 ± 
5.2~o, Fig. 4) and showed no tendency to normaliza-
lion (x96 = 46.8 ± 4.5016 of the standard value). 
Discussion 
In spite of numerollS reports of sepsis or septic shock, 
the pathogenesis of these d iseases remains largely un-
known. Since a c1ear definition of "septic shock" is 
not generally accepted, it is not surprising that 
etiology, hemodynamic criteria, severity or outcome 
are not comparable within or among the various 
studies. We have focused our efforts, therefore, on 
carrying out the biochemical measurements in pa-
tients with adefinite diagnosis 01 hyperdynamic septic 
shock according to Messmer [25] . Although the hy-
perdynamic phase is commonly considered 10 be the 
initial stage of the disorder, the present results 
demonstrate that Ihe plasma levels of thc measured 
variables were already abnormal when the first 
c1inical and haemodynamic signs appeared. 
Leukocyles, particularly the granulocytes, may 
playa cenlral part in the changes described. Aasen et 
al. [1] showed in an experimenfal study on lethai 
canine endotoxin shock that theTe was ade fi nite cor-
relation betwcen the initial fall in leukocyte count 
(probably combined with degranulation of these cells) 
and thc appearance of the leukocytic enzyme, 
elastase, in plasma. After a short de[ay, the well-
known disturbances of c1ouing, fibri nolysis and com-
plement systems arose indicating that consumption o f 
the plasma proteins mighl be due, at least in pan, to 
the activity of liberated leukocytic proteinases (1 8a]. 
The prominent leukocytosis following the initial 
leukopenia is thought to be one of the early defence 
reactions against the endotoxin. Il is, therefore, ap-
parent that the critenon of a "Ieukocytosis of more 
than 15000 cells/mm3" is an important but certainly 
not an early mark of sepsis [3, 10, 15). On the other 
hand, it is agreed that leukopenia in the later phase of 
the disease carries a very bad prognosis usually in-
dicating a fatal outcome (1 0] . Because of the small 
number (n = 3) of patients with leukopenia in our 
study, this assumption could not be verified statis-
tically. 
As an essential though indirect indication for the 
considerable liberation of proteinases from various 
body cells. especially leukocytes, during septic shock, 
we assumed a subslantial consumption or rurnover 0/ 
plasma proteinase inhibitors throughout the observa-
tion period. Studies clearly demonstrated that the 
turnover of the inter-a-lrypsin-inhibitor (ITI) is signi-
ficantly increased during septicemia {l7]. Moreover, 
studies in vitro showed thaI, of various proteinases 
examined, granulocytic elastase in parlicular was able 
to split off thc acid~stable inhibitor (ITIJoooo) from the 
native ITI (ITI I60000) most rapidly [16] . Sincc in the 
preseot study the level of native ITI was significamly 
reduced whereas the concentration of the acid-stable 
ITI-derived inhibitor was considerably elevated, it 
may be deduced that granulocytic proteinases are 
responsible for the prominent turnover of ITI in 
septic shock and septicemia. Measurement of the ITI 
turnover could be an indirect marker of leukocytic 
proteinase activity although the biological function of 
ITI I60000 oe lTI30000 is not yet deal. The broad-spec-
trum protei nase inhibitor a2-macroglobulin (a2M) 
seems 10 be mainly responsible for inhibition and 
elimination of neutral and acidic proteinase liberated 
from various body cells thus leading to a severe 
consumption of this most important proteinase-
elimination rcsource [5, 16,27,34]. Since a dramatic 
change, excecding variations wü hin the standard 
range, has not been noted during most inflammatory 
processes, the remarkably low level of a2M 
throughout the scptic shock phase is especially strik-
ing. Obviously, considerable amou nts of various pro-
teinases were permanently released imo the circula-
tion and eliminated by a2M. In the light of this find-
ing an important function can be ascribed to a2M in 
protecti ng the organism againsl nonspecific pro-
teolysis during septic shock. 
Consumplion of antithrombin 111, the most essen-
tial inhibitor for maintaining homeostasis of the dot-
ting system [16]. normally reflects the liberation of 
thrombin and factor Xa, whose inhibition and elim-
ination is primarily effccted by AT BI. With heparin 
medication to prcvent thrombosis or disseminated in-
travascuJar coaglliation, the assllmption of AT 111 is 
even further intensified, since the heparin AT 111 
complex also reaclS with other activated c10tting 
enzymes or plasma kalJikrein [5J. On the other hand, 
very recent results from our laboratory [1 8, 18a] have 
shown that purified AT III is proteolytically inac-
tivated even by catalytic amollnts of purified granu-
locytic elastase. Though in vitro effects should be 
transferred to in vivo conditions only with reserva-
tion, we assume that at least part of the AT m con-
sumption measured in tbe present trial may be due to 
proteolysis by granulocytic proteinases, especially in 
the patients who died during the sepuc shock phase. 
Besides turnover or consumption of several 
plasma proteinase inhibitors, the significantly low 
levels of two other plasma proteins, the fibrin-stabi-
lizing c1ottingjaclOr XIlI and complementjactor C3, 
may be also indicative of enhanced proteolytic 
activity due to degranulation of leukocytes. F XIII 
(24J seems to be preferred substrate of granulocytic 
proteinases, sißce in experimental septicemia the 
especially high consumption of th is cloning faetor 
could be prevented by previous systemic application 
of a specific inhibitor of granulocytic elastase and 
cathepsin G [3D). Moreover, Egbring et al. [7J demon-
strated that in the course of septicemia in man thc 
active transglutaminase (subunit A) and the carrier 
protein (subnnit S) of F XIII were consumed to a 
comparable degree. The reduction of both subunits, 
however, is not consistent with the usual consumptioll 
of F XIII during b lood c!otting, since subunit A and F 
XIII activity disappear completely after coagulaüon 
of plasma, whereas su bunits S remains unchanged. As 
the elastase-Iike granulocytic proteinase (ELP) caused 
a similar reduction of the activity of both F XIII sub-
units in plasma, it is very Iikely that proteolysis by 
ELP is involved in patients with septicemia or septic 
shock. 
Activation of the complement caseade in endo-
toxemia [2 , 26) proceeds primarily via the alternative 
pathway. This mayaiso be dedueed from the c1early 
lower level of eomplement factor C3 compared to C4 
during the shock phase. In this respect, two facts are 
of special interest; first, endotoxins can trigger thc 
release of elastase from granulocytes [1, 7J and 
second, elastase enables c1eavage of complemenl 
factor C4 in such a way that direct activation of the 
alternative pathway occurs [2, 19]. It may be 
assumed, therefore, that liberated elastase could at 
least be partly rcsponsible for the significant reduc-
tion of C3 throughout the hyperdynamic phase. 
Although there are numerous indirect indications 
that nonspedfic proteolytic degradation, particular!y 
due to granulocytic enzymes, may be involved in the 
prominent consumption o r proteinase inhibitors and 
other plasma proteins during the septic shock phase, 
it should be emphasized, that certainly a permanent 
activalion oj the clOlting, jibrinolysis and comple-
ment cascades via syslem-specijic proleinase occur-
red. An increased plasma concentration of jibrino-
peptide Ais especially remarkable in [his respect. This 
first split product of fibrinogen during c10tting is 
suggested to be highly characteristic for generated 
thrombin activity [23] . Similarly, activation of 
plasminogen and thus of fibrinolysis is responsible for 
the elevaled plasma levels oj jibrin(ogen) splil 
producis [33] . 
Summarizing thc results of our trial, it is dear that 
in hyperdynamic scptic shock the natural defence 
mcchanism against system-specific and nonspecific 
proteinases is considerably overstressed leading (0 
severe consumption of many vital plasma proteins. 
Administration of suitable proteinase inhibitors [9] 
should primarily prevent the exhaustion of endo-
genous plasma inhibitors such as al M or AT III and 
thus help to mai ntain the physiological balance. 
However, until systemic administration of inhibitors 
of thrombin or granulocytic proteinases is possibJe in 
humans, substitution with AT III [291 and Q1M con-
centrations might be a means of therapy. 
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